NEW YORK, May 10, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Medical Imaging Reports Bundle includes the following TriMark Publications reports at a 15% discount off the individual reports being purchased separately:
- European Medical Imaging Markets.
- Mammography World Markets.
- Medical Imaging Markets.
- Nuclear Cardiology Markets.
- Picture Archiving and Communications Systems (PACS).
- Positron Emission Tomography (PET) Markets.
- Ultrasound Markets.
Below are summaries of each report.
The European market for medical imaging equipment continues to thrive despite the impact of a global economic recession. As such, the European medical imaging market represents a dynamic and robust sector which will progressively represent an increasingly important sub-market within the medical device business. In order to provide a comprehensive and relevant analysis of the European medical imaging market, this TriMark Publications report covers the major medical imaging modalities of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT) and ultrasound. In order to reflect the ongoing shifts in the utilization of the modalities from single to multimodality systems, this study also includes analyzes of the European markets for PET/CT and SPECT/CT. While the European medical imaging market is dominated by a handful of multinational players, this report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in France, Germany, Italy, Spain, the United Kingdom, the Benelux countries, Scandinavia and the rest of Europe (ROE). Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included. To complete the analysis of the European market, this report also reviews other factors which are instrumental in shaping the future direction of Europe's medical imaging sector. The study looks at pricing, reimbursement issues, provides an assessment of the purchasing processes for capital equipment in each target market, and reviews alternative funding methods for capital equipment purchases and the regulatory environment with its inherent issues and challenges.
The women's mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher interest of individual patients and general healthcare consumers to take charge of their own health status. Continuous improvements in technology are resulting in a growing number of new imaging diagnostic tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. The emphasis in this TriMark Publications report is on those companies and products that are actively developing and marketing clinical laboratory instrumentation and reagents and supplies for performing diagnostic tests on conditions specifically related to women's health. This study concentrates on the mammography market segment in large worldwide markets such as the U.S., Japan and Europe. Certain areas that are not covered include what is generally characterized as digital imaging techniques instruments and reagents, PACS or other data storage methods, or other medical imaging technologies, although many of the instruments, reagents and techniques in the mammography market segment are intimately associated with these broader areas. Specialty areas in medical imaging are touched upon, since these segments are frequently a part of the overall analytical focus of companies marketing general mammography equipment. However, no effort is made to quantify the size of this broader market.
There will be a steady increase in demand for medical imaging services, along with pressures to improve the quality of healthcare delivered in the home and to lower its cost. The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment, and the higher interest of individual older baby boom patients and general healthcare consumers to monitor health status. Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. This sector includes all of the generally-accepted imaging activities that are currently used today, including X-ray and radiography, mammography, magnetic resonance imaging (MRI), ultrasound, gamma camera market, computed tomography (CT) scans and positron emission tomography (PET) scans. It examines these clinical measurement devices and their reagents and supplies as used in hospitals, clinics and doctor's offices. It also includes associated market segments like picture archiving and communications system (PACS) markets, cardiology imaging markets, three-dimensional (3D) imaging markets and other emerging technologies.
Nuclear imaging for cardiac diseases helps in accurately diagnosing the disease and blood flow blockages. Gamma cameras and positron emission tomography (PET) scanners are the key imaging devices used for cardiac procedures. Though nuclear imaging in cardiology faces competition from other methods, the impact is relatively limited. Demand for diagnostic medical imaging equipment is mainly driven by the number of diagnostic procedures. The application of PET's clinical use, its combined use with other imaging equipment and the current shift to PET/CT imaging and SPECT/CT imaging are the important factors driving the dramatic rise in procedural volumes. This TriMark Publications study discusses key products in nuclear cardiology and examines the trends that are stimulating this market. This market research report includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth. The primarily focus on three major segments of the nuclear cardiology market: 1) devices, 2) PACS (picture archiving and communications systems) and RIS (radiology information systems) and 3) radiopharmaceuticals. This examination discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the nuclear cardiology market soon. Detailed tables and charts with sales forecasts and market share data are also included.
During the past 35 years, ultrasound and nuclear medicine were introduced into clinical medicine, computed tomography (CT) revolutionized diagnostic procedures and magnetic resonance imaging (MRI) emerged, bringing new diagnostic information at the cellular level. X-ray morphed from analog films to digital, and virtually all medical images became "soft" files on the electronic networks. As imaging departments in healthcare facilities have migrated from film to digital, the display and storage systems have had to migrate too. These new digital imaging storage and display systems are called picture archiving and communication systems (PACS). Most PACSs handle images from various medical imaging instruments, including ultrasound, MRI, positron emission tomography (PET), CT, endoscopy, mammograms, etc. The focus of this TriMark Publications report is to analyze and describe the PACS market segments. PACS market penetration in the U.S. healthcare space has been significant, at almost 90%. A PACS network typically consists of a central server that stores a database containing the images connected to one or more clients via a local area network (LAN) or a wide area network (WAN) that provides or utilizes the images. More and more PACS utilize Internet-based technologies as their means of communication. This allows remote viewing and diagnosis with implications for both civilian and military healthcare facilities. Since radiology departments dominate the production of images, interconnections with radiology information systems (RIS) are also looked at in this study.
The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment. Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Part of that medical imaging improvement is coming from positron emission tomography (PET). PET is a scanning technique used in combination with small amounts of radio-labeled compounds to visualize the anatomy and function of the brain. The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics medical imaging market called PET scanning. This sector includes all of the generally accepted imaging activities that are currently used in PET, including equipment for PET, PET/CT, SPECT and the use of radiopharmaceuticals for imaging. It examines these clinical measurement devices and their reagents and supplies as used in hospitals and clinics. It also reviews associated clinical market segments in which PET scanning has taken a prominent role including cancer treatment, cardiology and neurology imaging markets.
During the past 35 years, ultrasound and nuclear medicine were introduced into clinical medicine, computed tomography (CT) revolutionized diagnostic procedures and magnetic resonance imaging (MRI) emerged, bringing new diagnostic information at the cellular level. X-ray morphed from analog films to digital, and virtually all medical images became "soft" files on the electronic superhighway. This TriMark Publications report describes the increasingly diversified market segment of the diagnostics market sector called ultrasonography or, more commonly, ultrasound. This sector currently includes prenatal ultrasonography, cardiac and cardiology-imaging ultrasound, and increasingly portable or handheld ultrasound, which some believe may partly to fully replace the ubiquitous use of stethoscopes over time. Emerging market segments such as three-dimensional (3D) and now four-dimensional (4D) ultrasound are also examined.
To order this report:
Intl: +1 805-652-2626
Copyright©2010 PR Newswire.
All rights reserved